JPS52114018A - Purification and isolation of hepatisis virus for producing vaccine - Google Patents

Purification and isolation of hepatisis virus for producing vaccine

Info

Publication number
JPS52114018A
JPS52114018A JP2853377A JP2853377A JPS52114018A JP S52114018 A JPS52114018 A JP S52114018A JP 2853377 A JP2853377 A JP 2853377A JP 2853377 A JP2853377 A JP 2853377A JP S52114018 A JPS52114018 A JP S52114018A
Authority
JP
Japan
Prior art keywords
hepatisis
virus
isolation
purification
producing vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2853377A
Other languages
English (en)
Japanese (ja)
Inventor
Orofu Anderuson Rarusu
Monika Einaruson Gudorun
Fuiritsupu Kapuran Rennaruto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phadia AB
Original Assignee
Kabi AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi AB filed Critical Kabi AB
Publication of JPS52114018A publication Critical patent/JPS52114018A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2853377A 1976-03-18 1977-03-15 Purification and isolation of hepatisis virus for producing vaccine Pending JPS52114018A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7603386A SE420977B (sv) 1976-03-18 1976-03-18 Forfarande for rening och isolering av hepatitvirus for vaccinframstellning

Publications (1)

Publication Number Publication Date
JPS52114018A true JPS52114018A (en) 1977-09-24

Family

ID=20327330

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2853377A Pending JPS52114018A (en) 1976-03-18 1977-03-15 Purification and isolation of hepatisis virus for producing vaccine

Country Status (10)

Country Link
US (1) US4138287A (US06724976-20040420-M00002.png)
JP (1) JPS52114018A (US06724976-20040420-M00002.png)
AU (1) AU506385B2 (US06724976-20040420-M00002.png)
BE (1) BE852416A (US06724976-20040420-M00002.png)
CA (1) CA1073815A (US06724976-20040420-M00002.png)
DE (1) DE2711773A1 (US06724976-20040420-M00002.png)
FR (1) FR2344629A1 (US06724976-20040420-M00002.png)
GB (1) GB1511997A (US06724976-20040420-M00002.png)
NL (1) NL7702784A (US06724976-20040420-M00002.png)
SE (1) SE420977B (US06724976-20040420-M00002.png)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59164727A (ja) * 1983-03-09 1984-09-17 Chemo Sero Therapeut Res Inst Ｂ型肝炎ウイルス表面抗原の精製方法
JPS59219239A (ja) * 1983-05-28 1984-12-10 Chemo Sero Therapeut Res Inst Ｂ型肝炎ウイルス表面抗原の精製方法

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4181713A (en) * 1978-10-30 1980-01-01 Merck & Co., Inc. Isolation of HBs Ag
US6297355B1 (en) 1978-12-22 2001-10-02 Biogen, Inc. Polypeptides displaying HBV antigenicity or hbv antigen specificity
US4242324A (en) * 1979-04-04 1980-12-30 Merck & Co., Inc. Hepatitis B antigen
US4395395A (en) * 1979-05-21 1983-07-26 The United States Of America As Represented By The Department Of Health And Human Services Detection of non-A, non-B hepatitis associated antigen
PL133476B1 (en) * 1981-06-10 1985-06-29 Akad Medyczna Method of obtaining pure antigen hba from human serum
AU8746582A (en) * 1981-09-02 1983-03-10 Biogen N.V. Hepatitis b virus e type antigen
US7767449B1 (en) * 1981-12-24 2010-08-03 Health Research Incorporated Methods using modified vaccinia virus
US4603112A (en) * 1981-12-24 1986-07-29 Health Research, Incorporated Modified vaccinia virus
US4511473A (en) * 1982-02-09 1985-04-16 Amf Incorporated Fibrous media containing millimicron-sized particulates
US4515714A (en) * 1983-03-09 1985-05-07 Juridicial Foundation, The Chemo-Semo-Sero-Therapeutic Research Institute Method for purification of hepatitis B virus surface antigen
AU571078B2 (en) * 1984-04-14 1988-03-31 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Purification of filamentous hemagglutinin
JPS6147185A (ja) * 1984-08-09 1986-03-07 Chemo Sero Therapeut Res Inst 日本脳炎ウイルスの精製方法
JPS6147186A (ja) * 1984-08-09 1986-03-07 Chemo Sero Therapeut Res Inst インフルエンザウイルスの精製方法
JPS6147187A (ja) * 1984-08-10 1986-03-07 Chemo Sero Therapeut Res Inst 狂犬病ウイルスの精製方法
JPS6153226A (ja) * 1984-08-24 1986-03-17 Chemo Sero Therapeut Res Inst 単純ヘルペスサブユニツトワクチンの精製方法
JPS61103895A (ja) * 1984-10-26 1986-05-22 Green Cross Corp:The ＨＢｓＡｇの精製方法
SE503844C2 (sv) 1989-02-09 1996-09-16 Pharmacia Ab Förfarande för rening av streptokinaser
US5447859A (en) * 1993-07-16 1995-09-05 Viagene Method for the purification or removal of retroviruses using sulfated cellulose
JP3615785B2 (ja) * 1994-04-28 2005-02-02 テルモ株式会社 Ｈｉｖ及びその関連物質除去材料
GB9804632D0 (en) * 1998-03-05 1998-04-29 Cantab Pharma Res Virus preparations and methods
US6221855B1 (en) * 1999-03-11 2001-04-24 Wake Forest University Regulation of nucleic acid expression by heparan sulfate and biological equivalents thereof
DE602004028736D1 (de) * 2003-06-20 2010-09-30 Microbix Biosystems Inc Verbesserungen bei der virusproduktion
EP3290513B1 (en) * 2004-06-01 2022-09-07 Genzyme Corporation Compositions and methods to prevent aav vector aggregation
EP2066418A4 (en) * 2006-09-29 2011-12-28 Ge Healthcare Bio Sciences Ab SEPARATION MATRIX FOR VIRAL PURIFICATION
CN114210310B (zh) * 2021-12-06 2023-09-29 武汉瑞法医疗器械有限公司 乙型肝炎病毒和HBsAg免疫吸附材料的制备方法及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636191A (en) * 1969-10-08 1972-01-18 Cancer Res Inst Vaccine against viral hepatitis and process
US3925152A (en) * 1971-06-18 1975-12-09 Exploaterings Ab Tbf Virus separation
US3896218A (en) * 1972-07-13 1975-07-22 Research Corp Radiommunoassay determining the hepatitis associated antigen content of blood
US3994870A (en) * 1974-01-31 1976-11-30 The Community Blood Council Of Greater New York, Inc. Purification of hepatitis B surface antigen
US3976767A (en) * 1975-04-14 1976-08-24 The New York Blood Center Purification of hepatitis B surface antigen by chromatography on agarose containing aminoalkyl residues
IL49752A (en) * 1975-07-09 1979-07-25 Kabi Ab Compositions having affinity for hepatitis virus and method for hepatitis virus removal or concentration

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59164727A (ja) * 1983-03-09 1984-09-17 Chemo Sero Therapeut Res Inst Ｂ型肝炎ウイルス表面抗原の精製方法
JPH0585527B2 (US06724976-20040420-M00002.png) * 1983-03-09 1993-12-07 Chemo Sero Therapeut Res Inst
JPS59219239A (ja) * 1983-05-28 1984-12-10 Chemo Sero Therapeut Res Inst Ｂ型肝炎ウイルス表面抗原の精製方法
JPH0235726B2 (US06724976-20040420-M00002.png) * 1983-05-28 1990-08-13 Kagaku Oyobi Ketsusei Ryoho Kenkyusho

Also Published As

Publication number Publication date
NL7702784A (nl) 1977-09-20
BE852416A (fr) 1977-07-01
AU506385B2 (en) 1979-12-20
DE2711773A1 (de) 1977-09-22
FR2344629A1 (fr) 1977-10-14
US4138287A (en) 1979-02-06
GB1511997A (en) 1978-05-24
FR2344629B1 (US06724976-20040420-M00002.png) 1983-07-18
SE7603386L (sv) 1977-09-19
SE420977B (sv) 1981-11-16
AU2331377A (en) 1978-09-21
CA1073815A (en) 1980-03-18

Similar Documents

Publication Publication Date Title
JPS52114018A (en) Purification and isolation of hepatisis virus for producing vaccine
JPS536428A (en) Preventing method of virus infection
JPS51121096A (en) Continuous preparation method of polybutyleneterephthalate
PH11916A (en) Catalyst and its process of preparation
ZA773397B (en) Method of purifying silicon
JPS51139619A (en) Hepatisis b vaccine
JPS56102786A (en) Preparation of concentrated virus group
JPS53144819A (en) Method of purifying silicon
GR63113B (en) Preparation process of meta-aryloxybenzaldehydes
JPS55129153A (en) Preparation of catalyst
JPS5726624A (en) Isolation of virus glycoprotein antigen and manufacture of vaccine thereby
JPS51133414A (en) Production of vaccine against viral hepatisis
GR61367B (en) Preparation process of 2-benzylpyrrolidines
JPS5341412A (en) Purification of extract including uterussevacuant
PT70556A (en) Vaccines against diseases caused by reo-virus and process for the preparation of those vaccines
IL52320A0 (en) P-isobutzyl hydratropate of guyiycol and process for its preparation
GR61183B (en) Preparation process of n-alkyldiphenylamines
JPS52125165A (en) Preparation of secretin and purification thereof
IL53038A (en) Preparation of certain nuclear-chlorinated benzotrichlorides
GR59194B (en) Preparation method of aryloxy-1 amino-3-propanols-2
RO77284A (ro) Procedeu pentru prepararea si purificarea rasinilor epoxidice
JPS5632373A (en) Manufacture of cordierite ceramics
JPS51142528A (en) Production of vaccine based on antigenic libosome fractionation
JPS52156920A (en) Proauction of raw influenza virus vaccine
NZ179108A (en) Isolation and purification of e colienterotoxin toxoid and vaccine therefrom